Article

No Evidence for Clonal Selection Due to Lentiviral Integration Sites in Human Induced Pluripotent Stem Cells

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
Stem Cells (Impact Factor: 7.7). 04/2010; 28(4):687-94. DOI: 10.1002/stem.322
Source: PubMed

ABSTRACT Derivation of induced pluripotent stem (iPS) cells requires the expression of defined transcription factors (among Oct3/4, Sox2, Klf4, c-Myc, Nanog, and Lin28) in the targeted cells. Lentiviral or standard retroviral gene transfer remains the most robust and commonly used approach. Low reprogramming frequency overall, and the higher efficiency of derivation utilizing integrating vectors compared to more recent nonviral approaches, suggests that gene activation or disruption via proviral integration sites (IS) may play a role in obtaining the pluripotent phenotype. We provide for the first time an extensive analysis of the lentiviral integration profile in human iPS cells. We identified a total of 78 independent IS in eight recently established iPS cell lines derived from either human fetal fibroblasts or newborn foreskin fibroblasts after lentiviral gene transfer of Oct4, Sox2, Nanog, and Lin28. The number of IS ranged from 5 to 15 IS per individual iPS clone, and 75 IS could be assigned to a unique chromosomal location. The different iPS clones had no IS in common. Expression analysis as well as extensive bioinformatic analysis did not reveal functional concordance of the lentiviral targeted genes between the different clones. Interestingly, in six of the eight iPS clones, some of the IS were found in pairs, integrated into the same chromosomal location within six base pairs of each other or in very close proximity. Our study supports recent reports that efficient reprogramming of human somatic cells is not dependent on insertional activation or deactivation of specific genes or gene classes.

Download full-text

Full-text

Available from: Thomas Winkler, Jul 30, 2014
0 Followers
 · 
137 Views
 · 
30 Downloads
  • Source
    • "The cloning of Dolly the sheep in 1997 dramatically changed the view of scientists on pluripotency and differentiation. The birth of Dolly clearly demonstrated that the nucleus of a somatic donor cell can be reprogrammed to a pluripotent state by factors present in the cytoplasm of an enucleated oocyte and the reconstructed embryo can ultimately lead to the development of a new organism (Wilmut et al. 1997). Since then, cloning has resulted in the successful production of live cloned offspring in more than 16 species, including cattle (Kato et al. 2000), mouse (Wakayama et al. 1998), goat (Baguisi et al. 1999), pig (Onishi et al. 2000; Polejaeva et al. 2000), cat (Shin et al. 2002), rabbit (Chesné et al. 2002), mule (Woods et al. 2003), horse (Galli et al. 2003), rat (Zhou et al. 2003), dog (Lee et al. 2005), ferret (Li et al. 2006a), red deer (Berg et al. 2007), buffalo (Shi et al. 2007), gray wolf (Oh et al. 2008) and camel (Wani et al. 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Pluripotent cells, such as embryonic stem (ES) cells, embryonic germ cells and embryonic carcinoma cells are a unique type of cell because they remain undifferentiated indefinitely in in vitro culture, show self-renewal and possess the ability to differentiate into derivatives of the three germ layers. These capabilities make them a unique in vitro model for studying development, differentiation and for targeted modification of the genome. True pluripotent ESCs have only been described in the laboratory mouse and rat. However, rodent physiology and anatomy differ substantially from that of humans, detracting from the value of the rodent model for studies of human diseases and the development of cellular therapies in regenerative medicine. Recently, progress in the isolation of pluripotent cells in farm animals has been made and new technologies for reprogramming of somatic cells into a pluripotent state have been developed. Prior to clinical application of therapeutic cells differentiated from pluripotent stem cells in human patients, their survival and the absence of tumourigenic potential must be assessed in suitable preclinical large animal models. The establishment of pluripotent cell lines in farm animals may provide new opportunities for the production of transgenic animals, would facilitate development and validation of large animal models for evaluating ESC-based therapies and would thus contribute to the improvement of human and animal health. This review summarises the recent progress in the derivation of pluripotent and reprogrammed cells from farm animals. We refer to our recent review on this area, to which this article is complementary.
    Reproduction Fertility and Development 12/2012; 25(1):103-28. DOI:10.1071/RD12265 · 2.58 Impact Factor
  • Source
    • "Notably, experiments with cells from " reprogrammable " mice support the conclusion that insertional mutagenesis is not a key driver of reprogramming as predicted from nonintegrative reprogramming studies and mapping of viral insertion sites (Aoi et al., 2008; Varas et al., 2009; Winkler et al., 2010). Consequently, one of the key questions in the reprogramming field has been whether only a particular subset of cells within the starting population, for example only those cells with a more undifferentiated state such as adult stem cells or progenitors, possess the ability to reach the iPS cell status. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Induced pluripotent stem (iPS) cells can be generated from various embryonic and adult cell types upon expression of a set of few transcription factors, most commonly consisting of Oct4, Sox2, cMyc, and Klf4, following a strategy originally published by Takahashi and Yamanaka (Takahashi and Yamanaka, 2006, Cell 126: 663-676). Since iPS cells are molecularly and functionally similar to embryonic stem (ES) cells, they provide a source of patient-specific pluripotent cells for regenerative medicine and disease modeling, and therefore have generated enormous scientific and public interest. The generation of iPS cells also presents a powerful tool for dissecting mechanisms that stabilize the differentiated state and are required for the establishment of pluripotency. In this review, we discuss our current view of the molecular mechanisms underlying transcription factor-mediated reprogramming to induced pluripotency.
    Journal of Cellular Physiology 04/2011; 226(4):868-78. DOI:10.1002/jcp.22450 · 3.87 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Retroviral vectors remain the most efficient and widely applied system for induction of pluripotency. However, mutagenic effects have been documented in both laboratory and clinical gene therapy studies, principally as a result of dysregulated host gene expression in the proximity of defined integration sites. Here, we report that cells with characteristics of pluripotent stem cells can be produced from normal human fibroblasts in the absence of reprogramming transcription factors (TFs) during lentiviral (LV) vector-mediated gene transfer. This occurred via induced alterations in host gene and microRNA (miRNA) expression and detrimental changes in karyotype. These findings demonstrate that vector-induced genotoxicity may alone play a role in somatic cell reprogramming derivation and urges caution when using integrating vectors in this setting. Clearer understanding of this process may additionally reveal novel insights into reprogramming pathways.
    Molecular Therapy 10/2010; 18(12):2139-45. DOI:10.1038/mt.2010.231 · 6.43 Impact Factor
Show more